132 filings
Page 3 of 7
8-K
jtgjh7 qc7o8zg
9 Aug 22
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update
8:08am
S-3ASR
tdyx6n5t5yr8ydrc
9 Aug 22
Automatic shelf registration
12:00am
D
zys3beh1mh1ie
18 Jul 22
$120.04M in equity, sold $120.04M, 23 investors
2:32pm
8-K
p2lrcwy5lt h5221i
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
4udwiy1w3jx
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
8ozb3xr
10 May 22
Gossamer Bio Announces First Quarter 2022 Financial Results and Provides Business Update
4:04pm
DEFA14A
xxxae2fu3ukf4 o7qmx8
27 Apr 22
Additional proxy soliciting materials
4:38pm
8-K
6o3xt tif
25 Apr 22
Results of Operations and Financial Condition
8:14am
S-8
19z0iv58by vrk
3 Mar 22
Registration of securities for employees
4:07pm
S-3ASR
e5o13hp
3 Mar 22
Automatic shelf registration
4:05pm
8-K
vvc22qtuw0k
3 Mar 22
Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update
4:02pm
8-K
5of45x ibr
8 Nov 21
Gossamer Bio Announces Third Quarter 2021 Financial Results and Provides Corporate Update
4:01pm
8-K
6p074nqx ay1txi
12 Oct 21
Regulation FD Disclosure
9:19am
8-K
iogd5
21 Sep 21
Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role
9:09am